After examining thousands of SARS-CoV-2 variants, Vopson discovered that 98.92% of mutations involved the deletion of nucleotides, while only 1.08% resulted in additions. This pattern, he argues ...

CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...

Each organism has a different code and a varying amount of nucleotides. A human has about three billion of them, whereas a virus, such as SARS-CoV-2 has about 30,000. Your genetic sequence can ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

It is important to understand the correlates of protection against SARS-CoV-2 and its variants for future vaccine design. Here, the authors show that the complement system enhances the antibody ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.

Scientists found that it can bind to human ACE2 receptors, similar to SARS-CoV-2 (the virus behind COVID-19). This suggests it has the potential for animal-to-human transmission. Experts note that ...

The discovery raises concerns about the virus's similarity to SARS-CoV-2 and its potential implications.

In the graphics that follow, Scientific American presents detailed explanations, current as of mid-June, into how SARS-CoV-2 sneaks inside human cells, makes copies of itself and bursts out to ...

Scientists found that the new virus can bind to human ACE2, making it similar to SARS-CoV-2 and NL63 (a common cold virus). The new virus called HKU5-CoV-2, discovered in bats in China ...